Hepatectomy Clinical Trials

13 recruitingLast updated: June 18, 2026

There are 13 actively recruiting hepatectomy clinical trials across 7 countries. Studies span Not Applicable, Phase 4, Phase 3. Top locations include Wuhan, Hubei, China, Guangzhou, Guangdong, China, Chenzhou, Hunan, China. Updated daily from ClinicalTrials.gov.


Hepatectomy Trials at a Glance

13 actively recruiting trials for hepatectomy are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Wuhan, Guangzhou, and Chenzhou. Lead sponsors running hepatectomy studies include Cheng Qi, First People's Hospital of Chenzhou, and Centre Hospitalier Universitaire de Saint Etienne.

Browse hepatectomy trials by phase

Treatments under study

About Hepatectomy Clinical Trials

Looking for clinical trials for Hepatectomy? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hepatectomy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hepatectomy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 4

Rice-derived Recombinant Human Serum Albumin for the Treatment of Hypoalbuminemia After Hepatectomy: A Prospective, Single-Arm, Exploratory Clinical Trial

Post-hepatectomy Hypoalbuminemia
Cheng Qi50 enrolled1 locationNCT07634549
Recruiting
Phase 4

The Effect of Remimazolam Versus Propofol on Postoperative Extubation Time

Laparoscopic Hepatectomy
Xuyu Zhang82 enrolled1 locationNCT07611344
Recruiting
Not Applicable

Routine Intraoperative White Test for Bile Leak Detection in Liver Resection: A Randomized Trial Protocol

Liver ResectionHepatectomyBile Leakage+2 more
Medical University of Warsaw260 enrolled1 locationNCT07511907
Recruiting
Phase 3

A Study of Methylprednisolone in People Having Liver Surgery

Hepatectomy
Memorial Sloan Kettering Cancer Center750 enrolled19 locationsNCT07507643
Recruiting
Not Applicable

Spinal Anesthesia For Enhanced Recovery After Liver Surgery

Pain, PostoperativeLiver NeoplasmsHepatectomy
University of Manitoba128 enrolled1 locationNCT03715517
Recruiting

The Use of Artificial Intelligence for the Prediction of Recurrence After Resection of Colorectal Liver Metastases

Colorectal Liver Metastasis (CRLM)Liver ResectionHepatectomy+1 more
Francesco De Cobelli1,000 enrolled1 locationNCT07385521
Recruiting
Not Applicable

Drain vs No Drain After Live Donor Hepatectomy

Donor Hepatectomy
Marengo Asia Hospitals80 enrolled1 locationNCT06769776
Recruiting

AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)

HepatectomyHepatecellular Carcinoma
Tongji Hospital353 enrolled1 locationNCT07062380
Recruiting

Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma

Hepatocellular CarcinomaHepatectomyLaparoscopic Hepatectomy
West China Hospital400 enrolled1 locationNCT06950827
Recruiting
Not Applicable

Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours

HepatectomyNGSStenosis of Bile Duct
IRCCS Azienda Ospedaliero-Universitaria di Bologna50 enrolled1 locationNCT06729944
Recruiting

Multimodal Image Registration for Helping Laparoscopic Liver Surgery Guidance

laparoscopyHepatectomy
Centre Hospitalier Universitaire de Saint Etienne40 enrolled1 locationNCT06044909
Recruiting
Not Applicable

Preoperative Sildenafil Administration for Hepatectomy

HepatectomyCentral Venous PressureHemodynamics Instability+1 more
First People's Hospital of Chenzhou16 enrolled1 locationNCT06237751
Recruiting
Not Applicable

Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE)

Hepatocellular CarcinomaRadiotherapyHepatectomy
Sun Yat-sen University148 enrolled1 locationNCT03732105